Conduit Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that acquires and develops deprioritized clinical assets from large pharmaceutical companies. It holds an exclusive license from AstraZeneca for HK-4 Glucokinase activators AZD1656 and AZD5658 (targeting autoimmune disorders) and AZD5904 (idiopathic male infertility). The company also owns proprietary solid-form cocrystal intellectual property for AZD1656 and leverages AI/cybernetics technology via a partnership with SARBORG Limited to enhance drug repurposing and clinical trial monitoring.
expected 2026-12-01
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-28 | 2024-12-31 | 0001641172-25-001246 | EDGAR | 105K words |
| 2024-04-16 | 2023-12-31 | 0001493152-24-014889 | EDGAR | 99K words |
| 2023-03-28 | 2022-12-31 | 0001493152-23-009306 | EDGAR | — |
| 2022-03-29 | 2021-12-31 | 0001493152-22-008049 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001493152-26-037458 | EDGAR | 30K words |
| 2026-07-15 | 2026-03-31 | 0001493152-26-033380 | EDGAR | 25K words |
| 2025-11-13 | 2025-09-30 | 0001493152-25-022373 | EDGAR | 32K words |
| 2025-08-14 | 2025-06-30 | 0001641172-25-024140 | EDGAR | 33K words |
| 2025-05-15 | 2025-03-31 | 0001641172-25-010405 | EDGAR | 28K words |
| 2024-11-14 | 2024-09-30 | 0001493152-24-046088 | EDGAR | 31K words |
| 2024-08-12 | 2024-06-30 | 0001493152-24-031385 | EDGAR | 28K words |
| 2024-05-14 | 2024-03-31 | 0001493152-24-019230 | EDGAR | 25K words |
| 2023-11-20 | 2023-09-30 | 0001493152-23-042176 | EDGAR | 30K words |
| 2023-08-14 | 2023-06-30 | 0001493152-23-028647 | EDGAR | 21K words |
| 2023-05-15 | 2023-03-31 | 0001493152-23-017281 | EDGAR | 20K words |
| 2022-11-07 | 2022-09-30 | 0001493152-22-030830 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-25 | 0001493152-26-044248 | EDGAR | 1K words |
| 2026-09-18 | 0001493152-26-043398 | EDGAR | 10K words |
| 2026-09-04 | 0001493152-26-041533 | EDGAR | 10K words |
| 2026-09-01 | 0001493152-26-040929 | EDGAR | 7K words |
| 2026-09-01 | 0001493152-26-041016 | EDGAR | 1K words |
| 2026-08-06 | 0001493152-26-036361 | EDGAR | 7K words |
| 2026-07-31 | 0001493152-26-035682 | EDGAR | 10K words |
| 2026-07-29 | 0001493152-26-035202 | EDGAR | 1K words |
| 2026-07-16 | 0001493152-26-033455 | EDGAR | 1K words |
| 2026-03-25 | 0001493152-26-012538 | EDGAR | 1K words |
119 total filings indexed. 93 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001896212 |
| Ticker | CDT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.cdtequity.com |
| Listed | 2023-09-25 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CDT (~200 tokens, structured JSON with cryptographic provenance)